Hemi orolingual angioedema

Khurana, Dheeraj; Sharma, Mukesh; Prabhakar, Sudesh
July 2008
Annals of Indian Academy of Neurology;Jul2008, Vol. 11 Issue 3, p199
Academic Journal
The article discusses the clinical case of a 50-year-old woman with right sided hemiparesis who developed hemiorolingual edema. It notes that the patient developed the condition following completion of intravenous (IV) recombinant tissue plasminogen activator (r-tPA) infusion yet was resolved over the next 24 hours. It mentions that angioedema can result to life threatening asphyxia, requiring intubation for the patient. It cites increased production of bradykinin following r-tPA infusion as the cause of angioedema in the patient.


Related Articles

  • ANGIOEDEMA HEREDITARIO GUIA DE TRATAMIENTO. Malbr�n, Alejandro; Romero, Diego S. Fern�ndez; Men�ndez, Alejandra // Medicina (Buenos Aires);2012, Vol. 72 Issue 1, p119 

    Hereditary angioedema (HAE) is a rare autosomal dominant disease, characterized by episodes of edema involving the skin, gastrointestinal tract and larynx. HAE has a historical asphyxia mortality of 15% to 50%. It is the consequence of functional C1 inhibitor deficiency. The identification of...

  • Alteplase/irbesartan interaction.  // Reactions Weekly;11/20/2010, Issue 1328, p7 

    The article describes the case of an 82-year-old woman who developed orolingual angioedema while undergoing alteplase therapy for stroke while receiving irbesartan.

  • Effect of intradermal bradykinin after inhibition of antiotensin converting enzyme. Ferner, R.E.; Simpson, Judy M.; Rawlins, M.D. // British Medical Journal (Clinical Research Edition);5/2/1987, Vol. 294 Issue 6580, p1119 

    Examines effect of intradermal bradykinin on angio-oedema. Impact of angiotensin converting enzyme inhibitors on intradermal bradykinin; Explanation on cause of angio-oedema in susceptible patients; Rationalization on coughing and flushing after angiotensin converting enzyme application.

  • Lisinopril/plasminogen activators interaction.  // Reactions Weekly;Aug2014, Vol. 1513 Issue 1, p26 

    The article presents a case study of a 75-year-old woman who developed the angioedema and epistaxis after receiving the lisinopril and recombinant tissue plasminogen activator (rtPA) for the treatment of acute ischaemic stroke and she was treated with methylprednisolone and diphenhydramine.

  • Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey. Longhurst, Hilary J.; Aberer, Werner; Bouillet, Laurence; Caballero, Teresa; Fabien, Vincent; Zanichelli, Andrea; Maurer, Marcus // Allergy & Asthma Proceedings;Sep/Oct2015, Vol. 36 Issue 5, p399 

    Purpose: Phase 3 icatibant trials showed that most hereditary angioedema (HAE) (C1 inhibitor deficiency) acute attacks were treated successfully with one injection of icatibant, a selective bradykinin B2 receptor antagonist. We conducted a post hoc analysis of icatibant reinjection for HAE type...

  • The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology. Bygum, Anette; Aygren-Prsn, Emel; Caballero, Teresa; Beusterien, Kathleen; Gholizadeh, Shadi; Musingarimi, Patience; Wait, Suzanne; Boysen, Henrik // BMC Dermatology;2012, Vol. 12 Issue 1, p4 

    Background: Hereditary angioedema (HAE) is a rare but serious disease marked by swelling attacks in the extremities, face, trunk, airway, or abdominal areas that can be spontaneous or the result of trauma and other triggers. It can be life-threatening due to the risk of asphyxiation. While there...

  • In vivo bradykinin B2 receptor activation reduces renal fibrosis. Schanstra, Joost P.; Neau, Eric; Drogoz, Pascale; Arevalo Gomez, Miguel A.; Miguel Lopez Novoa, Jose; Calise, Denis; Pecher, Christiane; Bader, Michael; Girolami, Jean-Pierre; Bascands, Jean-Loup // Journal of Clinical Investigation;8/1/2002, Vol. 110 Issue 3, p371 

    Presents a study that showed that genetic ablation or pharmacological blockade of the bradykinin B2 receptor increases unilateral ureteral obstruction (UUO)-induced interstitial fibrosis in mice, whereas rats expressing increased endogenous bradykinin show reduced UUO-induced interstitial...

  • Emergent Treatment of Angioedema. Rosa Bohrer, Kristyn // International Student Journal of Nurse Anesthesia;Summer2012, Vol. 11 Issue 2, p19 

    Angioedema is a phenomenon that rapidly affects the tissues in the respiratory tract within minutes to hours of initial presentation. Characterizing features are sudden onset of laryngeal edema leading to airway compromise and asphyxiation. It has an asymmetric distribution with involvement of...

  • Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations. Gower, Richard G.; Lumry, William R.; Davis-Lorton, Mark A.; Johnston, Douglas T.; Busse, Paula J. // Allergy & Asthma Proceedings;May/Jun2012, Vol. 33 Issue 3, p235 

    Hereditary angioedema (HAE) results from mutations in the C1-esterase inhibitor (C1 INH) gene that decrease production of C1 INH or render it dysfunctional. HAE is characterized by recurrent, unpredictable, bradykinin-mediated edema of the extremities, face, genitalia, trunk, gastrointestinal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics